MEDIA ADVISORY: BIO VentureForum 2002Oct 2 2002
8:30 - 8:50 a.m.RALSTON BALLROOMThe Current Environment for Venture FinancingMark Heesen, president,... |
|
MEDIA ADVISORY: BIO VentureForum 2002Oct 1 2002
8:30 - 8:45 a.m.RALSTON BALLROOMWelcoming RemarksCarl B. Feldbaum, president, Biotechnology Industry... |
|
Sponsor of New Calif. Stem Cell Law to Address BIO VentureForum 2002Oct 1 2002
SAN FRANCISCO (October 1, 2002) – California State Senator Deborah Ortiz (D-Sacramento) will be available for media interviews to discuss the new state law endorsing embryonic stem cell... |
|
BIO STATEMENT ON FDA COMMISSIONER NOMINATIONSep 25 2002
WASHINGTON, D.C. (September 25, 2002) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement regarding White House intentions to nominate Mark B... |
|
131 Life Science Companies Featured at BIO VentureForum 2002Sep 18 2002
Washington, D.C. (September 18, 2002) - The Biotechnology Industry Organization (BIO) today released a list of 131 biotechnology companies chosen to present at BIO VentureForum... |
|
BIO VentureForum 2002 Looks At Opportunities and Challenges of Private Financing in Today’s EconomySep 12 2002
Washington, D.C. (September 12, 2002) – The Biotechnology Industry Organization (BIO) will host its second annual BIO VentureForum on Oct. 1-2, in San Francisco, showcasing more than 130 leading... |
|
FDA Streamlining of Biopharmaceutical Review A Welcome DevelopmentSep 6 2002
In response to the FDA’s plan to consolidate reviews of pharmaceutical products, including biologics, at the Center for Drug Evaluation and Research, BIO President Carl B. Feldbaum today... |
|
New Privacy Rule Protects Patients and Helps ResearchAug 12 2002
WASHINGTON, D.C. (August 12, 2002) – Biotechnology Industry Organization (BIO) Vice President for Bioethics Michael Werner issued the following statement regarding changes to the privacy... |
|
BIO Supports New Food Safety PolicyAug 1 2002
Washington, D.C. (August 1, 2002) – Dr. Michael J. Phillips, Executive Director of Food and Agriculture of the Biotechnology Industry Organization (BIO), issued the following statement today in... |
|
Senate Attacks Patents After Failing to Pass Medicare Prescription Drug CoverageJul 31 2002
WASHINGTON, D.C. (July 31, 2002) - Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement regarding today’s Senate passage of S. 812:“It&... |
